Íæż½ã½ã

  • By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
OK
Advertisement
Clinical Trials Arena06:30Lyme Disease Pfizer Pfizer Vaccine
Biopharma Reporter09:22Lyme Disease Pfizer Pfizer Vaccine
Pharmaceutical Technology11:43Canada The Lancet
Zacks09:04Pfizer Pharma
Benzinga11:16
ENDPOINTS10:56Pharma
In the last 10 minutes
TipRanks16:25
In the last 6 hours
Pharmaceutical Technology11:43
Earlier today
GlobeNewswire (Press Release)01:02
In the last 7 days
International Financing Review12:25 13-Sep-24
ENDPOINTS10:56 13-Sep-24
Law36009:56 13-Sep-24
TipRanks08:07 13-Sep-24
GlobeNewswire (Press Release)02:32 13-Sep-24
Valneva (Press Release)16:08 12-Sep-24
In the last month
PMLiVE07:32 6-Sep-24
GlobeNewswire (Press Release)12:11 4-Sep-24
ENDPOINTS15:38 3-Sep-24
Benzinga14:41 3-Sep-24
Benzinga11:16 3-Sep-24
Scrip Pharma Intelligence10:53 3-Sep-24
Biopharma Reporter09:22 3-Sep-24
Zacks09:04 3-Sep-24
TipRanks06:33 3-Sep-24
Clinical Trials Arena06:30 3-Sep-24
FierceBiotech05:04 3-Sep-24
pharmaphorum04:41 3-Sep-24
Valneva (Press Release)00:59 3-Sep-24
DGAP10:10 20-Aug-24
The Scotsman23:54 19-Aug-24
view more headlines
18 Sep 16:25

Valneva News

Latest news on Valneva, a French biotech company that develops and commercialises vaccines for infectious diseases.


Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.